Have a personal or library account? Click to login

References

  1. 1. GORNIK H.L., GERHARD-HERMAN M., BECKMAN J.A. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005; 2 3(22):5211-6.10.1200/JCO.2005.00.745
  2. 2. MAISCH B.I., SEFEROVIĆ P.M., RISTIĆ A.D., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004 Apr; 25(7):587-610.10.1016/j.ehj.2004.02.002
  3. 3. REFAAT M.M., KATZ W.E. Neoplastic Pericardial Effusion. Clinical Cardiology 2011; 34(10):593-8.10.1002/clc.20936
  4. 4. LEWINTER M.M., TISCHLER M.D. Pericardial diseases. In: Bonow R.O., Mann D.L., Zipes D.P., Libby P., eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Ed 9. Philadelphia, 2011, Saunders, 1651-1670.
  5. 5. SAGRISTÀ-SAULEDA J., MERCÉ J., PERMANYER-MIRALDA G., SOLER-SOLER J. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000; 109(2):95-101.10.1016/S0002-9343(00)00459-9
  6. 6. MAGGIOLINI S., OSCULATI G., VITALE G. Utility and safety of diagnostic pericardiocentesis. European Heart Journal 2005; 26(10):1046-7.10.1093/eurheartj/ehi240
  7. 7. SIDAWY M.K, ALI S.Z. Fine needle aspiration cytology. Elsevier Health Sciences, 2007.
  8. 8. RIZZARDI C., BARREZI E., BROLLO A., CASSETTI P., SCNEIDER M., MELATO M. Primary pericardial mesothelioma in an asbestos-exposed patient with previous heart surgery. Anticancer Research 2010; 30 (1):1323-6.
  9. 9. KWON H.Y., CHO K.I., KIM S.M., et al. A rare case with primary undifferentiated carcinoma of pericardium. Journal of Cardiovascular Ultrasound. 2010; 18(3):104-107.10.4250/jcu.2010.18.3.104
  10. 10. PETCU D.P., PETCU C., POPESCU C.F., BĂTĂIOSU C., ALEXANDRU D. Clinical and cytological correlations in pericardial effusions with cardiac tamponade. Rom J Morphol Embryol. 2009; 50(2):251-6.
  11. 11. KOSS G.L., MELAMED M.R., Effusions in the absence of cancer and effusions in the presence of cancer. In: Koss G.L., Melamed M.R. (eds), Koss’ diagnostic cytology and its histopathologic bases, 5th edition, Lippincott Williams & Wilkins, Philadelphia, 2006.
  12. 12. REUTER H., BURGESS L., VAN VUUREN W., DOUBELL A., Diagnosing tuberculous pericarditis. QJM, 2006; 99(12):827-39.10.1093/qjmed/hcl123
  13. 13. FIOCCO M., KRASNA M.J., The management of malignant pleural and pericardial effusions. Hematol Oncol Clin North Am 1997; 11(2):253-65.10.1016/S0889-8588(05)70429-9
  14. 14. WANG P.C., YANG K.Y., CHAO J.Y., LIU J.M., PERNG R.P., YEN S.H., Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest 2000; 118(3):744-749.10.1378/chest.118.3.74410988197
  15. 15. DRAGOESCU E.A, LIU L. Pericardial fluid cytology: An analysis of 128 specimens over a 6 year period. Cancer Cytopathol. 2013, 121:242-251.10.1002/cncy.2124623362233
  16. 16. HAE-OK JUNG. Pericardial effusion and pericardiocentesis: Role of echocardiography. Korean Circ J. 2012; 42(11): 725-34.10.4070/kcj.2012.42.11.725351870523236323
  17. 17. KARATOLIOS K., PANKUWEIT S., MAISCH B. Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion. Heart Fail Rev. 2013; 18(3):337-44. 10.1007/s10741-012-9327-x22638889
DOI: https://doi.org/10.1515/rjim-2016-0026 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 179 - 183
Submitted on: Jan 27, 2016
|
Published on: Sep 22, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Alexandra Kalogeraki, George Lazopoulos, Georgios Z. Papadakis, Dimitrios Tamiolakis, Iliana Karvela-Kalogeraki, Mihailos Karvelas-Kalogerakis, John Segredakis, Michael Papadakis, Eleni Moustou, Galateia Datseri, George E. Chalkiadakis, Maria Tzardi, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.